Orchid To Develop Merck’s Anti-Coagulant; To Buy Majority Stake In Diakron
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Chennai-based injectible cephalosporin manufacturer Orchid Chemicals will develop and manufacture an oral anti-coagulant drug that was initially discovered by U.S. drug maker Merck